Michael B. Smith
Clinical Assistant Professor of Psychiatry (Academic)
faculty
Obstetrics & Gynecology, College of Medicine
Research Areas
Biography and Research Information
OverviewAI-generated summary
Michael B. Smith is a Clinical Assistant Professor in Psychiatry and Obstetrics & Gynecology at the University of Arkansas for Medical Sciences (UAMS). He completed his medical degree at UAMS and his OB/GYN residency at Wake Forest University. Dr. Smith's clinical interests lie within obstetrics and gynecology, a field he was inspired to enter by breast cancer survivors during medical school. He values the diversity of patients and cases his specialty presents and returned to UAMS to serve the people of Arkansas, appreciating the institution's comprehensive care and resources.
Dr. Smith has received the Red Sash Award for his impact on medical education, as nominated by medical students, and was also recognized as the Best Resident Teacher in Obstetrics and Gynecology during his residency. His research has explored topics such as the role of physical activity in employment disparities after breast cancer, for which he received NIH funding. His publication record includes work on blood pressure management after endovascular therapy for acute ischemic stroke, conservative oxygen therapy in critically ill patients, and the role of heme lactoperoxidase in iodide oxidation and its potential antiviral applications, including in relation to SARS-CoV-2. He also has research on social network analysis of fertility discussions online and the patient and economic impact of pediatric sepsis pathways.
With a highly cited researcher designation, Dr. Smith has an h-index of 73 and over 16,000 citations across nearly 300 publications. He is a principal investigator on federal grants, including a $126,501 award from the NIH/National Institute on Minority Health and Health Disparities. He maintains an active lab website and leads a research group, collaborating with several researchers at UAMS.
Research Overview
Dr. Michael Smith completed his medical degree at the University of Arkansas for Medical Sciences in Little Rock, Arkansas. He then completed his residency in Obstetrics and Gynecology at Wake Forest University, North Carolina Baptist Medical Center in Winston Salem, North Carolina. During his residency he was awarded the Best Resident Teacher in Obstetrics and Gynecology. His clinical interest is in obstetrics and gynecology. During his second year of medical school, he was inspired by breast cancer survivors to follow a career in OB/GYN. He enjoys the variety of patients and cases that his field offers. Dr. Smith is originally from Little Rock, but grew up in nearby Hot Springs, Arkansas. He came back to serve his fellow Arkansans at UAMS. In 2010, he received the Red Sash Award for significant impact on medical education as nominated by medical students. He enjoys practicing at UAMS for its comprehensive care and numerous resources in technology as well as staff members.
Metrics
- h-index: 73
- Publications: 297
- Citations: 16,794
Selected Publications
-
Describing rural pharmacists' communication about the COVID-19 vaccine (2025)
-
1339: STANDARDIZING EXTUBATION READINESS ASSESSMENT TO REDUCE FAILURE IN THE PICU: QI INITIATIVE (2025)
Federal Grants 1 $126,501 total
Explaining the potential role of physical activity in employment disparities after breast cancer
Grants & Funding
- DP24-004, PRC, Core: Health Promotion and Disease Prevention Research Centers NIH Co-Investigator
Collaboration Network
Top Collaborators
- Blood Pressure Management After Endovascular Therapy for Acute Ischemic Stroke
- Tumor Embolic Stroke: The Importance of Pathological Assessment of Clots after Thrombectomy
- 531 Novel inflammatory gene expression changes occur within the occluded vasculature of large vessel ischemic stroke
- Blood Pressure Management After Endovascular Therapy for Acute Ischemic Stroke
- Tumor Embolic Stroke: The Importance of Pathological Assessment of Clots after Thrombectomy
- 531 Novel inflammatory gene expression changes occur within the occluded vasculature of large vessel ischemic stroke
- Blood Pressure Management After Endovascular Therapy for Acute Ischemic Stroke
- Tumor Embolic Stroke: The Importance of Pathological Assessment of Clots after Thrombectomy
- 531 Novel inflammatory gene expression changes occur within the occluded vasculature of large vessel ischemic stroke
- Patient and economic impact of implementing a paediatric sepsis pathway in emergency departments in Queensland, Australia
- Patient and economic impact of implementing a paediatric sepsis pathway in emergency departments in Queensland, Australia
- Patient and economic impact of implementing a paediatric sepsis pathway in emergency departments in Queensland, Australia
- Patient and economic impact of implementing a paediatric sepsis pathway in emergency departments in Queensland, Australia
- Patient and economic impact of implementing a paediatric sepsis pathway in emergency departments in Queensland, Australia
- Patient and economic impact of implementing a paediatric sepsis pathway in emergency departments in Queensland, Australia
- Brief Resolved Unexplained Events (Formerly Apparent Life-Threatening Events) and Evaluation of Lower-Risk Infants
- Brief Resolved Unexplained Events (Formerly Apparent Life-Threatening Events) and Evaluation of Lower-Risk Infants: Executive Summary
- Brief Resolved Unexplained Events (Formerly Apparent Life-Threatening Events) and Evaluation of Lower-Risk Infants
- Brief Resolved Unexplained Events (Formerly Apparent Life-Threatening Events) and Evaluation of Lower-Risk Infants: Executive Summary
- Brief Resolved Unexplained Events (Formerly Apparent Life-Threatening Events) and Evaluation of Lower-Risk Infants
- Brief Resolved Unexplained Events (Formerly Apparent Life-Threatening Events) and Evaluation of Lower-Risk Infants: Executive Summary
- Brief Resolved Unexplained Events (Formerly Apparent Life-Threatening Events) and Evaluation of Lower-Risk Infants
- Brief Resolved Unexplained Events (Formerly Apparent Life-Threatening Events) and Evaluation of Lower-Risk Infants: Executive Summary
- Brief Resolved Unexplained Events (Formerly Apparent Life-Threatening Events) and Evaluation of Lower-Risk Infants
- Brief Resolved Unexplained Events (Formerly Apparent Life-Threatening Events) and Evaluation of Lower-Risk Infants: Executive Summary
- Brief Resolved Unexplained Events (Formerly Apparent Life-Threatening Events) and Evaluation of Lower-Risk Infants
- Brief Resolved Unexplained Events (Formerly Apparent Life-Threatening Events) and Evaluation of Lower-Risk Infants: Executive Summary
- Brief Resolved Unexplained Events (Formerly Apparent Life-Threatening Events) and Evaluation of Lower-Risk Infants
- Brief Resolved Unexplained Events (Formerly Apparent Life-Threatening Events) and Evaluation of Lower-Risk Infants: Executive Summary
- Brief Resolved Unexplained Events (Formerly Apparent Life-Threatening Events) and Evaluation of Lower-Risk Infants
- Brief Resolved Unexplained Events (Formerly Apparent Life-Threatening Events) and Evaluation of Lower-Risk Infants: Executive Summary
- Brief Resolved Unexplained Events (Formerly Apparent Life-Threatening Events) and Evaluation of Lower-Risk Infants
- Brief Resolved Unexplained Events (Formerly Apparent Life-Threatening Events) and Evaluation of Lower-Risk Infants: Executive Summary
Similar Researchers
Based on overlapping research topics